Neuroblastoma News and Research

RSS

Neuroblastoma is cancer that arises in immature nerve cells and affects mostly infants and children.

Immunotherapy using CAR NKT cells shows promise for treating solid tumors

Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer properties in murine tumor models, have been developed into a novel form of immunotherapy to treat patients with cancer.

14 Oct 2020

Treatment using immune system T cells preserves vision of mice with retinoblastoma

A treatment that uses immune system T cells, combined with an immune-boosting drug packaged in an injectable gel, was found to preserve the vision of mice implanted with tissue from a human eye cancer known as retinoblastoma.

13 Oct 2020

New drug shows promise in the treatment of neuroblastoma

A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine.

7 Oct 2020

Highly expressed DDX1 gene is associated with poor survival of neuroblastoma

Neuroblastoma, is often diagnosed during childhood. It is responsible for causing 15% of all malignancy death in childhood.

14 Sep 2020

Removing copper from the blood can destroy some of the deadliest cancers

Australian researchers have discovered that removing copper from the blood can destroy some of the deadliest cancers that are resistant to immunotherapy using models of the disease.

20 Aug 2020

MRI Scan Used For Heart Disease Could Also Pick Out Aggressive Cancers

An MRI scan used for heart disease could help assess whether children's cancers are especially aggressive and spot early signs that treatments are working.

29 Jun 2020